Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Taysha Gene Therapies Inc TSHA

Healthcare Biotechnology
Taysha Gene Therapies Inc is a clinical-stage biotechnology company, which is focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. The Company’s lead clinical program, TSHA-102, is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder. The Company is evaluating TSHA-102 in the... see more

Bullboard (NDAQ:TSHA)

View:
User Avatar Image
(9)
•••
  • MikeTesterX
Post by MikeTesteron Aug 02, 2024 5:42am

Taysha Gene Therapies, Inc. (TSHA): Advancing a Promising Ge

https://beyondspx.com/2024/08/01/taysha-gene-therapies-inc-tsha-advancing-a-promising-gene-therapy-pipeline-for-rare-neurological-disorders/
22
User Avatar Image
(276)
•••
  • whytestocksX
Post by whytestockson Jun 26, 2024 6:00pm

Taysha Gene Therapies Announces Pricing of Public Offering o

Just In: $TSHA Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsDALLAS, June 26, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a ...more  
39
User Avatar Image
(276)
•••
  • whytestocksX
Post by whytestockson Jun 25, 2024 10:30pm

Taysha Gene Therapies Announces Proposed Public Offering of

Just In: $TSHA Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsDALLAS, June 25, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a ...more  
69
User Avatar Image
(276)
•••
  • whytestocksX
Post by whytestockson Jun 18, 2024 6:30pm

Taysha Gene Therapies Announces Positive Clinical Data Acros

NEWS: $TSHA Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett ...more  
50
User Avatar Image
(276)
•••
  • whytestocksX
Post by whytestockson Apr 09, 2024 10:30am

TSHA Price Target Alert: $9.00. Issued by Raymond James

Just In: $TSHA TSHA Price Target Alert: $9.00. Issued by Raymond James2024-04-09 05:00:04 ET Christopher Raymond from Raymond James issued a price target of $9.00 for TSHA on 2024-04-09 03:56:00. The ...more  
64
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Aug 24, 2023 10:23am

TSHA....Looks like there's more paper to layout

the Greater Fool....90 cent paper
72
User Avatar Image
(72)
•••
  • IseneschalX
Post by Iseneschalon Aug 14, 2023 1:14pm

TSHA ....done like dinner ; )

Guhnite
58